Table 5.
Baseline demographics, risk factors, and incidence of SSI with 1-year surveillance protocol for patients with IT pump systems
| Characteristic | Pre-IPB Group | Post-IPB Group | ||
|---|---|---|---|---|
| All Patients | Infected Patients | All Patients | Infected Patients | |
| No. of patients, (%) | 93 (100%) | 8 (8.6%) | 100 (100%) | 2 (2.0%) |
| Average Age in years | 46 ± 16 | 39 ± 15 | 47 ± 14 | 44 ± 18 |
| Sex (Male:Female) | 58:35 | 4:4 | 64:36 | 0:2 |
| Characteristic | Total Patients | Infected Patients, (%) | Total Patients | Infected Patients, (%) |
| Previous Implant revision (non-infectious) | 2 | 0 (0%) | 8 | 0 (0%) |
| Previous implant-related SSI | 1 | 1 (100%) | 4 | 1 (25%) |
| Obesity (BMI > 30kg/m2) | 22 | 4 (18.2%) | 15 | 1 (6.7%) |
| Diabetes | 4 | 0 (0%) | 9 | 0 (0%) |
| Paraplegia | 29 | 2 (6.9%) | 31 | 1 (3.2%) |
| Quadriplegia/Quadriparesis | 51 | 5 (9.8%) | 67 | 1 (1.5%) |
| Neurogenic bowel/bladder | 66 | 8 (12.1%) | 66 | 2 (3.0%) |
| Spinal Cord Injury | 32 | 2 (6.3%) | 44 | 0 (0%) |
| Cerebral Palsy | 24 | 4 (16.7%) | 24 | 1 (4.2%) |
| Demyelinating disorder | 19 | 1 (5.3%) | 26 | 1 (3.8%) |
| History of stroke, ICH | 13 | 1 (7.7%) | 14 | 0 (0%) |
| Cancer | 16 | 1 (6.3%) | 5 | 0 (0%) |
| Statin use | 12 | 0 (0%) | 19 | 0 (0%) |
BMI = body mass index
IPB = infection prevention bundle
ICH = intracerebral hemorrhage
IT = intrathecal
SSI = surgical site infection
No. = number